An Early Shot at Stopping PDAC

The progression of pancreatic ductal adenocarcinoma (PDAC) from precursor lesions presents an opportunity for cancer prevention. Haldar et al. developed mKRAS-VAX, a peptide vaccine targeting six common KRAS mutations in PDAC, and evaluated it in a phase I clinical trial.